A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio

被引:18
作者
Boulton, DW
Arnaud, P
DeVane, CL
机构
[1] Med Univ S Carolina, Dept Psychiat & Behav Sci, Lab Drug Disposit & Pharmacogenet, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA
关键词
cortisol ratio; CYP3A; drug interactions; methadone;
D O I
10.1046/j.1365-2125.2001.01360.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To examine the effect of a single oral dose of methadone on cytochrome P450 (CYP) 3A activity using the urinary 6 beta -hydroxycortisol to cortisol ratio (UCR) as a marker of CYP3A activity. Methods A single oral dose (0.2 mg kg(-1)) of rac-methadone was administered to eight healthy female volunteers. Frequent blood samples and all urine over seven time periods was collected For 96 h following dosing. The UCR and the concentration of the major CYP3A metabolite of methadone, EDDP, were measured in urine. Methadone enantiomer concentrations were determined in plasma and urine. All quantifications were performed by validated high performance liquid chromatography assays. Results In all Volunteers a significant decline of the UCR from immediately predose values was observed at the 4-8 and 8-12 h collection periods (P < 0.05, 95% CI for the differences. 0.4.16 and 0.6.16, respectively) with a return to immediately predose values after 2-3 days, suggesting methadone was an inhibitor of CYP3A. The UCR was found to be significantly correlated with the amount of EDDP excreted in the urine and with the area under the plasma concentration vs time profile for total (R + S) methadone supporting in vitro data that CYP3A is primarily responsible for EDDP formation and has a significant influence on methadone disposition. Conclusions Methadone appears to be a CYP3A inhibitor in vivo following a single oral dose and measurements of the urinary cortisol ratio appear to be a useful index to follow this inhibition.
引用
收藏
页码:350 / 354
页数:5
相关论文
共 39 条
[1]  
ANGGARD E, 1975, CLIN PHARMACOL THER, V17, P258
[2]   BIOTRANSFORMATION OF METHADONE IN MAN - SYNTHESIS AND IDENTIFICATION OF A MAJOR METABOLITE [J].
BECKETT, AH ;
TAYLOR, JF ;
CASY, AF ;
HASSAN, MMA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (10) :754-&
[3]  
Boulton DW, 2000, CHIRALITY, V12, P681, DOI 10.1002/1520-636X(2000)12:9<681::AID-CHIR7>3.3.CO
[4]  
2-A
[5]   The effect of fluconazole on the clinical pharmacokinetics of methadone [J].
Cobb, MN ;
Desai, J ;
Brown, LS ;
Zannikos, PN ;
Rainey, PM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (06) :655-662
[6]   BINDING OF D-METHADONE, L-METHADONE, AND DL-METHADONE TO PROTEINS IN PLASMA OF HEALTHY-VOLUNTEERS - ROLE OF THE VARIANTS OF ALPHA-1-ACID GLYCOPROTEIN [J].
EAP, CB ;
CUENDET, C ;
BAUMANN, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) :338-346
[7]   Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone [J].
Eap, CB ;
Bertschy, G ;
Powell, K ;
Baumann, P .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (02) :113-117
[8]   High interindividual variability of methadone enantiomer blood levels to dose ratios [J].
Eap, CB ;
Bertschy, G ;
Baumann, P ;
Finkbeiner, T ;
Gastpar, T ;
Gastpar, M ;
Scherbaum, N .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (01) :89-90
[9]   Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: Interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics [J].
Eap, CB ;
Finkbeiner, T ;
Gastpar, M ;
Scherbaum, N ;
Powell, K ;
Baumann, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (05) :385-389
[10]   FORTNIGHTLY REVIEW - METHADONE-MAINTENANCE TREATMENT IN OPIATE DEPENDENCE - A REVIEW [J].
FARRELL, M ;
WARD, J ;
MATTICK, R ;
HALL, W ;
STIMSON, GV ;
JARLAIS, DD ;
GOSSOP, M ;
STRANG, J .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6960) :997-1001